NewAmsterdam Pharma

NAMS

Market cap $4.26B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$37

9% downside

High target

positive

1 neutral

33%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Wells Fargo Yanan Zhu 100% 1-yr NAMS win rate				25 Aug ‘25 1 month ago
RBC Capital Leonid Timashev 100% 1-yr NAMS win rate				7 Aug ‘25 2 months ago
Goldman Sachs Asad Haider				17 Jul ‘25 3 months ago